Investigational Site Number : 8040009

Ivano-Frankivsk 76019

0 studies enrolling now · 4 studies all time

What they study most

Chronic Kidney Diseases, Heart Failure, Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis — Running, not enrolling
• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early